Inhibition of HIF-1α by the anticancer drug TAS106 enhances X-ray-induced apoptosis in vitro and in vivo

In a previous study, we showed that a novel anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106, ECyd) increased the antitumour efficacy of X-irradiation. However, its effects on hypoxic cells in tumours remain unclarified. Here, we show that TAS106 enhances the induction of apo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasui, H, Ogura, A, Asanuma, T, Matsuda, A, Kashiwakura, I, Kuwabara, M, Inanami, O
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579694/
https://www.ncbi.nlm.nih.gov/pubmed/18854835
http://dx.doi.org/10.1038/sj.bjc.6604720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579694/
https://www.ncbi.nlm.nih.gov/pubmed/18854835
http://dx.doi.org/10.1038/sj.bjc.6604720

Ejemplares similares